Clinical Trial Update: Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of cannabis in participants with posttraumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Snippet

Sponsor: Tilray | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: COMPLETED